世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
遺伝子治療薬の世界市場レポート2022年版Global Gene Therapy Sales Market Report 2022 遺伝子治療は、病気と闘ったり予防したりするために、人の細胞に遺伝物質を導入する実験的治療法である。研究者たちは、重症複合免疫不全症、血友病、パーキンソン病、がん、さらにはHIVなど、多くの病気に対する... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー遺伝子治療は、病気と闘ったり予防したりするために、人の細胞に遺伝物質を導入する実験的治療法である。研究者たちは、重症複合免疫不全症、血友病、パーキンソン病、がん、さらにはHIVなど、多くの病気に対する遺伝子治療を、さまざまなアプローチで研究している。遺伝子は、"ベクター "と呼ばれる運搬体を用いて細胞に送り込むことができる。遺伝子治療で使用されるベクターの最も一般的な種類はウイルスです。遺伝子治療に使用されるウイルスは、安全性を高めるために改変されていますが、それでも遺伝子治療にはリスクがあります。この技術はまだ初期段階にあります。市場の分析と洞察遺伝子治療の世界市場 COVID-19の大流行により、遺伝子治療の世界市場規模は2021年に7077.6百万米ドルと推定され、レビュー期間中にCAGR27.6％で2028年までに7077.6百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮すると、2021年に遺伝子治療世界市場の％を占めたタイプ別は、2028年には百万米ドルの値を示し、COVID-19後の期間に修正された％のCAGRで成長すると予測されます。一方、タイプ別セグメントは、この予測期間を通して％CAGRに変更されています。 世界の遺伝子治療の主要企業は、バイオジェン、ノバルティス、ギリアド・サイエンシズなどです。世界の上位3社で約75％のシェアを占めています。 北米が最大の市場であり、そのシェアは約60％、次いで欧州とアジア太平洋地域がそれぞれ約35％を占めています。 製品別では、Non-viral Gene Therapyが最大のセグメントであり、約55%のシェアを占めています。また、アプリケーション別では、神経疾患が最も多く、次いでがんが多い。 遺伝子治療の世界市場範囲と市場規模 遺伝子治療の世界市場は、企業別、地域（国）別、タイプ別、用途別に分類されています。遺伝子治療の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント分析では、地域（国）別、タイプ別、アプリケーション別の売上、収益、2017-2028年までの予測に焦点を当てています。 タイプ別セグメント ウイルス性遺伝子治療 非ウイルス性遺伝子治療 用途別セグメント 神経系疾患 癌 その他 地域別 米国 欧州 中国 日本 東南アジア インド その他の地域 会社別 バイオジェン ノバルティス ギリアド・サイエンシズ サレプタ・セラピューティック アルニラム・ファーマシューティカルズ アムジェン スパーク・セラピューティック アクセア・セラピューティック ブルーバード・バイオ サンウェイバイオテック シビオノ アンジェス オーチャード・セラピューティック ヒト幹細胞研究所 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gene Therapy Market Size by Type (2017 VS 2021VS 2028) 1.2.2 Viral Gene Therapy 1.2.3 Non-Viral Gene Therapy 1.3 Market by Application 1.3.1 Global Gene Therapy Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Neurological Diseases 1.3.3 Cancer 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gene Therapy Market Perspective (2017-2028) 2.2 Global Gene Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.3 Global Gene Therapy Revenue Market Share by Region (2017-2022) 2.4 Global Gene Therapy Revenue Forecast by Region (2023-2028) 2.5 Geographic Market Analysis: Market Facts & Figures 2.5.1 United States Gene Therapy Estimates and Projections (2017-2028) 2.5.2 Europe Gene Therapy Estimates and Projections (2017-2028) 2.5.3 China Gene Therapy Estimates and Projections (2017-2028) 2.5.4 Japan Gene Therapy Estimates and Projections (2017-2028) 2.5.5 Southeast Asia Gene Therapy Estimates and Projections (2017-2028) 2.5.6 India Gene Therapy Estimates and Projections (2017-2028) 3 Global Gene Therapy Competition Landscape by Players 3.1 Global Top Gene Therapy Players by Revenue (2017-2022) 3.1.1 Global Top Gene Therapy Players by Revenue (2017-2022) 3.1.2 Global Gene Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Gene Therapy Revenue 3.4 Global Gene Therapy Market Concentration Ratio 3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2021 3.5 Gene Therapy Key Players Head office and Area Served 3.6 Key Players Gene Therapy Product Solution and Service 3.7 Date of Enter into Gene Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gene Therapy Breakdown Data by Type 4.1 Global Gene Therapy Historic Market Size by Type (2017-2022) 4.2 Global Gene Therapy Forecasted Market Size by Type (2023-2028) 5 Gene Therapy Breakdown Data by Application 5.1 Global Gene Therapy Historic Market Size by Application (2017-2022) 5.2 Global Gene Therapy Forecasted Market Size by Application (2023-2028) 6 United States Gene Therapy Market Facts & Figures 6.1 United States Gene Therapy Revenue by Company (2017-2022) 6.2 United States Gene Therapy Market Size by Type 6.2.1 United States Gene Therapy Market Size by Type (2017-2022) 6.2.2 United States Gene Therapy Market Size by Type (2023-2028) 6.2.3 United States Gene Therapy Market Share by Type (2017-2028) 6.3 United States Gene Therapy Market Size by Application 6.3.1 United States Gene Therapy Market Size by Application (2017-2022) 6.3.2 United States Gene Therapy Market Size by Application (2023-2028) 6.3.3 United States Gene Therapy Market Share by Application (2017-2028) 7 Europe Gene Therapy Market Facts & Figures 7.1 Europe Gene Therapy Revenue by Company (2017-2022) 7.2 Europe Gene Therapy Market Size by Type 7.2.1 Europe Gene Therapy Market Size by Type (2017-2022) 7.2.2 Europe Gene Therapy Market Size by Type (2023-2028) 7.2.3 Europe Gene Therapy Market Share by Type (2017-2028) 7.3 Europe Gene Therapy Market Size by Application 7.3.1 Europe Gene Therapy Market Size by Application (2017-2022) 7.3.2 Europe Gene Therapy Market Size by Application (2023-2028) 7.3.3 Europe Gene Therapy Market Share by Application (2017-2028) 8 China Gene Therapy Market Facts & Figures 8.1 China Gene Therapy Revenue by Company (2017-2022) 8.2 China Gene Therapy Market Size by Type 8.2.1 China Gene Therapy Market Size by Type (2017-2022) 8.2.2 China Gene Therapy Market Size by Type (2023-2028) 8.2.3 China Gene Therapy Market Share by Type (2017-2028) 8.3 China Gene Therapy Market Size by Application 8.3.1 China Gene Therapy Market Size by Application (2017-2022) 8.3.2 China Gene Therapy Market Size by Application (2023-2028) 8.3.3 China Gene Therapy Market Share by Application (2017-2028) 9 Japan Gene Therapy Market Facts & Figures 9.1 Japan Gene Therapy Revenue by Company (2017-2022) 9.2 Japan Gene Therapy Market Size by Type 9.2.1 Japan Gene Therapy Market Size by Type (2017-2022) 9.2.2 Japan Gene Therapy Market Size by Type (2023-2028) 9.2.3 Japan Gene Therapy Market Share by Type (2017-2028) 9.3 Japan Gene Therapy Market Size by Application 9.3.1 Japan Gene Therapy Market Size by Application (2017-2022) 9.3.2 Japan Gene Therapy Market Size by Application (2023-2028) 9.3.3 Japan Gene Therapy Market Share by Application (2017-2028) 10 Southeast Asia Gene Therapy Market Facts & Figures 10.1 Southeast Asia Gene Therapy Revenue by Company (2017-2022) 10.2 Southeast Asia Gene Therapy Market Size by Type 10.2.1 Southeast Asia Gene Therapy Market Size by Type (2017-2022) 10.2.2 Southeast Asia Gene Therapy Market Size by Type (2023-2028) 10.2.3 Southeast Asia Gene Therapy Market Share by Type (2017-2028) 10.3 Southeast Asia Gene Therapy Market Size by Application 10.3.1 Southeast Asia Gene Therapy Market Size by Application (2017-2022) 10.3.2 Southeast Asia Gene Therapy Market Size by Application (2023-2028) 10.3.3 Southeast Asia Gene Therapy Market Share by Application (2017-2028) 11 India Gene Therapy Market Facts & Figures 11.1 India Gene Therapy Revenue by Company (2017-2022) 11.2 India Gene Therapy Market Size by Type 11.2.1 India Gene Therapy Market Size by Type (2017-2022) 11.2.2 India Gene Therapy Market Size by Type (2023-2028) 11.2.3 India Gene Therapy Market Share by Type (2017-2028) 11.3 India Gene Therapy Market Size by Application 11.3.1 India Gene Therapy Market Size by Application (2017-2022) 11.3.2 India Gene Therapy Market Size by Application (2023-2028) 11.3.3 India Gene Therapy Market Share by Application (2017-2028) 12 Key Players Profiles 12.1 Biogen 12.1.1 Biogen Company Details 12.1.2 Biogen Business Overview 12.1.3 Biogen Gene Therapy Introduction 12.1.4 Biogen Revenue in Gene Therapy Business (2017-2022) 12.1.5 Biogen Recent Development 12.2 Novartis 12.2.1 Novartis Company Details 12.2.2 Novartis Business Overview 12.2.3 Novartis Gene Therapy Introduction 12.2.4 Novartis Revenue in Gene Therapy Business (2017-2022) 12.2.5 Novartis Recent Development 12.3 Gilead Sciences 12.3.1 Gilead Sciences Company Details 12.3.2 Gilead Sciences Business Overview 12.3.3 Gilead Sciences Gene Therapy Introduction 12.3.4 Gilead Sciences Revenue in Gene Therapy Business (2017-2022) 12.3.5 Gilead Sciences Recent Development 12.4 Sarepta Therapeutics 12.4.1 Sarepta Therapeutics Company Details 12.4.2 Sarepta Therapeutics Business Overview 12.4.3 Sarepta Therapeutics Gene Therapy Introduction 12.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2017-2022) 12.4.5 Sarepta Therapeutics Recent Development 12.5 Alnylam Pharmaceuticals 12.5.1 Alnylam Pharmaceuticals Company Details 12.5.2 Alnylam Pharmaceuticals Business Overview 12.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction 12.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2017-2022) 12.5.5 Alnylam Pharmaceuticals Recent Development 12.6 Amgen 12.6.1 Amgen Company Details 12.6.2 Amgen Business Overview 12.6.3 Amgen Gene Therapy Introduction 12.6.4 Amgen Revenue in Gene Therapy Business (2017-2022) 12.6.5 Amgen Recent Development 12.7 Spark Therapeutics 12.7.1 Spark Therapeutics Company Details 12.7.2 Spark Therapeutics Business Overview 12.7.3 Spark Therapeutics Gene Therapy Introduction 12.7.4 Spark Therapeutics Revenue in Gene Therapy Business (2017-2022) 12.7.5 Spark Therapeutics Recent Development 12.8 Akcea Therapeutics 12.8.1 Akcea Therapeutics Company Details 12.8.2 Akcea Therapeutics Business Overview 12.8.3 Akcea Therapeutics Gene Therapy Introduction 12.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2017-2022) 12.8.5 Akcea Therapeutics Recent Development 12.9 bluebird bio 12.9.1 bluebird bio Company Details 12.9.2 bluebird bio Business Overview 12.9.3 bluebird bio Gene Therapy Introduction 12.9.4 bluebird bio Revenue in Gene Therapy Business (2017-2022) 12.9.5 bluebird bio Recent Development 12.10 Sunway Biotech 12.10.1 Sunway Biotech Company Details 12.10.2 Sunway Biotech Business Overview 12.10.3 Sunway Biotech Gene Therapy Introduction 12.10.4 Sunway Biotech Revenue in Gene Therapy Business (2017-2022) 12.10.5 Sunway Biotech Recent Development 12.11 SIBIONO 12.11.1 SIBIONO Company Details 12.11.2 SIBIONO Business Overview 12.11.3 SIBIONO Gene Therapy Introduction 12.11.4 SIBIONO Revenue in Gene Therapy Business (2017-2022) 12.11.5 SIBIONO Recent Development 12.12 AnGes 12.12.1 AnGes Company Details 12.12.2 AnGes Business Overview 12.12.3 AnGes Gene Therapy Introduction 12.12.4 AnGes Revenue in Gene Therapy Business (2017-2022) 12.12.5 AnGes Recent Development 12.13 Orchard Therapeutics 12.13.1 Orchard Therapeutics Company Details 12.13.2 Orchard Therapeutics Business Overview 12.13.3 Orchard Therapeutics Gene Therapy Introduction 12.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2017-2022) 12.13.5 Orchard Therapeutics Recent Development 12.14 Human Stem Cells Institute 12.14.1 Human Stem Cells Institute Company Details 12.14.2 Human Stem Cells Institute Business Overview 12.14.3 Human Stem Cells Institute Gene Therapy Introduction 12.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2017-2022) 12.14.5 Human Stem Cells Institute Recent Development 13 Market Dynamics 13.1 Gene Therapy Industry Trends 13.2 Gene Therapy Market Drivers 13.3 Gene Therapy Market Challenges 13.4 Gene Therapy Market Restraints 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author List 15.3 Disclaimer
SummaryGene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy. Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gene Therapy Market Size by Type (2017 VS 2021VS 2028) 1.2.2 Viral Gene Therapy 1.2.3 Non-Viral Gene Therapy 1.3 Market by Application 1.3.1 Global Gene Therapy Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Neurological Diseases 1.3.3 Cancer 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gene Therapy Market Perspective (2017-2028) 2.2 Global Gene Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.3 Global Gene Therapy Revenue Market Share by Region (2017-2022) 2.4 Global Gene Therapy Revenue Forecast by Region (2023-2028) 2.5 Geographic Market Analysis: Market Facts & Figures 2.5.1 United States Gene Therapy Estimates and Projections (2017-2028) 2.5.2 Europe Gene Therapy Estimates and Projections (2017-2028) 2.5.3 China Gene Therapy Estimates and Projections (2017-2028) 2.5.4 Japan Gene Therapy Estimates and Projections (2017-2028) 2.5.5 Southeast Asia Gene Therapy Estimates and Projections (2017-2028) 2.5.6 India Gene Therapy Estimates and Projections (2017-2028) 3 Global Gene Therapy Competition Landscape by Players 3.1 Global Top Gene Therapy Players by Revenue (2017-2022) 3.1.1 Global Top Gene Therapy Players by Revenue (2017-2022) 3.1.2 Global Gene Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Gene Therapy Revenue 3.4 Global Gene Therapy Market Concentration Ratio 3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2021 3.5 Gene Therapy Key Players Head office and Area Served 3.6 Key Players Gene Therapy Product Solution and Service 3.7 Date of Enter into Gene Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gene Therapy Breakdown Data by Type 4.1 Global Gene Therapy Historic Market Size by Type (2017-2022) 4.2 Global Gene Therapy Forecasted Market Size by Type (2023-2028) 5 Gene Therapy Breakdown Data by Application 5.1 Global Gene Therapy Historic Market Size by Application (2017-2022) 5.2 Global Gene Therapy Forecasted Market Size by Application (2023-2028) 6 United States Gene Therapy Market Facts & Figures 6.1 United States Gene Therapy Revenue by Company (2017-2022) 6.2 United States Gene Therapy Market Size by Type 6.2.1 United States Gene Therapy Market Size by Type (2017-2022) 6.2.2 United States Gene Therapy Market Size by Type (2023-2028) 6.2.3 United States Gene Therapy Market Share by Type (2017-2028) 6.3 United States Gene Therapy Market Size by Application 6.3.1 United States Gene Therapy Market Size by Application (2017-2022) 6.3.2 United States Gene Therapy Market Size by Application (2023-2028) 6.3.3 United States Gene Therapy Market Share by Application (2017-2028) 7 Europe Gene Therapy Market Facts & Figures 7.1 Europe Gene Therapy Revenue by Company (2017-2022) 7.2 Europe Gene Therapy Market Size by Type 7.2.1 Europe Gene Therapy Market Size by Type (2017-2022) 7.2.2 Europe Gene Therapy Market Size by Type (2023-2028) 7.2.3 Europe Gene Therapy Market Share by Type (2017-2028) 7.3 Europe Gene Therapy Market Size by Application 7.3.1 Europe Gene Therapy Market Size by Application (2017-2022) 7.3.2 Europe Gene Therapy Market Size by Application (2023-2028) 7.3.3 Europe Gene Therapy Market Share by Application (2017-2028) 8 China Gene Therapy Market Facts & Figures 8.1 China Gene Therapy Revenue by Company (2017-2022) 8.2 China Gene Therapy Market Size by Type 8.2.1 China Gene Therapy Market Size by Type (2017-2022) 8.2.2 China Gene Therapy Market Size by Type (2023-2028) 8.2.3 China Gene Therapy Market Share by Type (2017-2028) 8.3 China Gene Therapy Market Size by Application 8.3.1 China Gene Therapy Market Size by Application (2017-2022) 8.3.2 China Gene Therapy Market Size by Application (2023-2028) 8.3.3 China Gene Therapy Market Share by Application (2017-2028) 9 Japan Gene Therapy Market Facts & Figures 9.1 Japan Gene Therapy Revenue by Company (2017-2022) 9.2 Japan Gene Therapy Market Size by Type 9.2.1 Japan Gene Therapy Market Size by Type (2017-2022) 9.2.2 Japan Gene Therapy Market Size by Type (2023-2028) 9.2.3 Japan Gene Therapy Market Share by Type (2017-2028) 9.3 Japan Gene Therapy Market Size by Application 9.3.1 Japan Gene Therapy Market Size by Application (2017-2022) 9.3.2 Japan Gene Therapy Market Size by Application (2023-2028) 9.3.3 Japan Gene Therapy Market Share by Application (2017-2028) 10 Southeast Asia Gene Therapy Market Facts & Figures 10.1 Southeast Asia Gene Therapy Revenue by Company (2017-2022) 10.2 Southeast Asia Gene Therapy Market Size by Type 10.2.1 Southeast Asia Gene Therapy Market Size by Type (2017-2022) 10.2.2 Southeast Asia Gene Therapy Market Size by Type (2023-2028) 10.2.3 Southeast Asia Gene Therapy Market Share by Type (2017-2028) 10.3 Southeast Asia Gene Therapy Market Size by Application 10.3.1 Southeast Asia Gene Therapy Market Size by Application (2017-2022) 10.3.2 Southeast Asia Gene Therapy Market Size by Application (2023-2028) 10.3.3 Southeast Asia Gene Therapy Market Share by Application (2017-2028) 11 India Gene Therapy Market Facts & Figures 11.1 India Gene Therapy Revenue by Company (2017-2022) 11.2 India Gene Therapy Market Size by Type 11.2.1 India Gene Therapy Market Size by Type (2017-2022) 11.2.2 India Gene Therapy Market Size by Type (2023-2028) 11.2.3 India Gene Therapy Market Share by Type (2017-2028) 11.3 India Gene Therapy Market Size by Application 11.3.1 India Gene Therapy Market Size by Application (2017-2022) 11.3.2 India Gene Therapy Market Size by Application (2023-2028) 11.3.3 India Gene Therapy Market Share by Application (2017-2028) 12 Key Players Profiles 12.1 Biogen 12.1.1 Biogen Company Details 12.1.2 Biogen Business Overview 12.1.3 Biogen Gene Therapy Introduction 12.1.4 Biogen Revenue in Gene Therapy Business (2017-2022) 12.1.5 Biogen Recent Development 12.2 Novartis 12.2.1 Novartis Company Details 12.2.2 Novartis Business Overview 12.2.3 Novartis Gene Therapy Introduction 12.2.4 Novartis Revenue in Gene Therapy Business (2017-2022) 12.2.5 Novartis Recent Development 12.3 Gilead Sciences 12.3.1 Gilead Sciences Company Details 12.3.2 Gilead Sciences Business Overview 12.3.3 Gilead Sciences Gene Therapy Introduction 12.3.4 Gilead Sciences Revenue in Gene Therapy Business (2017-2022) 12.3.5 Gilead Sciences Recent Development 12.4 Sarepta Therapeutics 12.4.1 Sarepta Therapeutics Company Details 12.4.2 Sarepta Therapeutics Business Overview 12.4.3 Sarepta Therapeutics Gene Therapy Introduction 12.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2017-2022) 12.4.5 Sarepta Therapeutics Recent Development 12.5 Alnylam Pharmaceuticals 12.5.1 Alnylam Pharmaceuticals Company Details 12.5.2 Alnylam Pharmaceuticals Business Overview 12.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction 12.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2017-2022) 12.5.5 Alnylam Pharmaceuticals Recent Development 12.6 Amgen 12.6.1 Amgen Company Details 12.6.2 Amgen Business Overview 12.6.3 Amgen Gene Therapy Introduction 12.6.4 Amgen Revenue in Gene Therapy Business (2017-2022) 12.6.5 Amgen Recent Development 12.7 Spark Therapeutics 12.7.1 Spark Therapeutics Company Details 12.7.2 Spark Therapeutics Business Overview 12.7.3 Spark Therapeutics Gene Therapy Introduction 12.7.4 Spark Therapeutics Revenue in Gene Therapy Business (2017-2022) 12.7.5 Spark Therapeutics Recent Development 12.8 Akcea Therapeutics 12.8.1 Akcea Therapeutics Company Details 12.8.2 Akcea Therapeutics Business Overview 12.8.3 Akcea Therapeutics Gene Therapy Introduction 12.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2017-2022) 12.8.5 Akcea Therapeutics Recent Development 12.9 bluebird bio 12.9.1 bluebird bio Company Details 12.9.2 bluebird bio Business Overview 12.9.3 bluebird bio Gene Therapy Introduction 12.9.4 bluebird bio Revenue in Gene Therapy Business (2017-2022) 12.9.5 bluebird bio Recent Development 12.10 Sunway Biotech 12.10.1 Sunway Biotech Company Details 12.10.2 Sunway Biotech Business Overview 12.10.3 Sunway Biotech Gene Therapy Introduction 12.10.4 Sunway Biotech Revenue in Gene Therapy Business (2017-2022) 12.10.5 Sunway Biotech Recent Development 12.11 SIBIONO 12.11.1 SIBIONO Company Details 12.11.2 SIBIONO Business Overview 12.11.3 SIBIONO Gene Therapy Introduction 12.11.4 SIBIONO Revenue in Gene Therapy Business (2017-2022) 12.11.5 SIBIONO Recent Development 12.12 AnGes 12.12.1 AnGes Company Details 12.12.2 AnGes Business Overview 12.12.3 AnGes Gene Therapy Introduction 12.12.4 AnGes Revenue in Gene Therapy Business (2017-2022) 12.12.5 AnGes Recent Development 12.13 Orchard Therapeutics 12.13.1 Orchard Therapeutics Company Details 12.13.2 Orchard Therapeutics Business Overview 12.13.3 Orchard Therapeutics Gene Therapy Introduction 12.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2017-2022) 12.13.5 Orchard Therapeutics Recent Development 12.14 Human Stem Cells Institute 12.14.1 Human Stem Cells Institute Company Details 12.14.2 Human Stem Cells Institute Business Overview 12.14.3 Human Stem Cells Institute Gene Therapy Introduction 12.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2017-2022) 12.14.5 Human Stem Cells Institute Recent Development 13 Market Dynamics 13.1 Gene Therapy Industry Trends 13.2 Gene Therapy Market Drivers 13.3 Gene Therapy Market Challenges 13.4 Gene Therapy Market Restraints 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author List 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療IT）の最新刊レポート
QYResearch社の医療分野での最新刊レポート
本レポートと同じKEY WORD（gene）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
